Don Valentine was diagnosed with early symptomatic Alzheimer’s disease, but, according to him and the doctors responsible for ...

A simpler method of analyzing blood samples for Alzheimer's disease has been tested in a large multi-center study.

The American Civil Liberties Union also filed a lawsuit last week, alleging that the federal agency and its parent department ...

As the Trump administration makes cuts to federal health agencies, some Alzheimer's experts are worried about the impact on ...

A new blood test identifies a key biomarker for Alzheimer’s disease, which may help make assessing the presence and stage of ...

New research reveals that the immune checkpoint molecule Tim-3 plays a critical role in how microglia, the brain’s immune cells, respond to Alzheimer’s disease.

Tim-3 is an immune checkpoint molecule involved in immunity and inflammation recently linked to late-onset Alzheimer's disease (AD), but its role in the brain was unknown until now. Researchers used ...

A new blood test test could determine how far Alzheimer's has progressed and could also help confirm whether another ...

Albers and colleagues are interested in whether olfactory dysfunction — the sometimes-subtle loss of sense of smell — can ...

Not getting enough of the deeper stages of sleep raises the risk of brain deterioration associated with Alzheimer’s disease, ...

Experimental drug NU-9—a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials ...

A new report explains how a woman with signs of Alzheimer's disease in her brain had no symptoms. Here's what her story can tell us about the disease.